The public health emergency may be over, but COVID-19 fraud enforcement did not pack up its briefcase and go home. In 2024, federal and state authorities kept chasing pandemic-era fraud with the energy of a tax auditor who just found a second spreadsheet. That is because the money was huge, the misconduct was wide-ranging, and the legal tools available to regulators and whistleblowers remain very much alive.

From Paycheck Protection Program loans and Economic Injury Disaster Loans to false Medicare billing, sham COVID test claims, fake cure marketing, and questionable Employee Retention Credit filings, enforcement agencies spent 2024 proving a simple point: pandemic fraud ages badly. Even when the crisis headlines fade, the paper trail does not. Banks keep records. Claims data stays searchable. Insiders keep talking. And the False Claims Act still gives the government and whistleblowers a powerful way to turn old misconduct into very current lawsuits.

That is why businesses, health care providers, lenders, laboratories, nonprofit organizations, and tax filers should treat 2024 as a warning shot, not a victory lap. The government is still tracing funds, testing eligibility claims, reviewing certifications, and comparing what applicants said then with what the data says now. In other words, 2024 was less about pandemic panic and more about pandemic cleanup.

Why COVID-19 Fraud Claims Stayed Hot in 2024

COVID-19 fraud claims continued in 2024 for one big reason: the enforcement pipeline is long. Pandemic relief programs moved money quickly, often before agencies had time to build strong front-end controls. That speed helped struggling businesses and patients, but it also created a classic “pay now, chase later” environment. Once that happens, the cleanup phase can stretch for years.

The government also has multiple lanes for enforcement. Some matters are criminal, such as wire fraud, bank fraud, conspiracy, or identity theft. Others are civil, especially under the False Claims Act, which allows the government to recover damages and penalties when someone knowingly submits or causes false claims to be submitted. And then there are administrative and consumer-protection actions, where agencies can suspend payments, exclude providers, seek injunctions, claw back funds, or ban deceptive marketing.

That layered system matters. A questionable PPP application may trigger a civil settlement. A Medicare billing pattern may become both a criminal investigation and a repayment dispute. A fake COVID product ad may invite FTC action even after the product craze has cooled off. One pandemic, many enforcement doors.

The Main Targets of 2024 Enforcement

1. PPP and EIDL loan fraud

PPP and EIDL enforcement remained one of the clearest examples of long-tail COVID accountability in 2024. Federal officials kept pursuing cases involving inflated payroll figures, hidden affiliates, duplicate applications, false necessity certifications, sham nonprofits, and forgiveness requests that rested on shaky facts. By 2024, the easy-money phase was over, and the document-comparison phase was in full swing.

That shift matters because pandemic loan fraud often leaves a neat trail: tax records, payroll reports, loan applications, forgiveness certifications, ownership structures, and bank transfers. If those records do not line up, trouble usually shows up wearing a suit and carrying subpoenas. Several 2024 settlements demonstrated exactly that pattern, including cases involving nonprofit organizations and dental businesses accused of improperly obtaining PPP loans. These cases also highlighted how often the government works with SBA-OIG and how frequently whistleblowers help push matters forward.

For businesses, the compliance lesson is painfully simple: if a company received COVID-era relief based on employee headcount, payroll size, affiliation rules, or eligibility representations, those statements should still be reviewable today. “We were moving fast” is an explanation, not a defense.

2. Health care billing and testing schemes

If 2024 had a recurring villain in the health care enforcement world, it was medically unnecessary COVID-related billing. Authorities continued targeting cases involving bogus testing, kickbacks, unnecessary respiratory panels, false uninsured program claims, improper testing reimbursements, and unsolicited over-the-counter test kit billing. Health care fraud cases like these kept showing up because claims data is measurable, anomalies are detectable, and patient complaints have a way of turning into government interest.

DOJ’s 2024 national health care fraud action underscored the point. COVID testing fraud did not disappear just because people stopped panic-buying hand sanitizer. Instead, some schemes evolved into more technical versions of the same old game: bill for services not requested, not needed, not provided, or not properly documented. That is the sort of behavior enforcement agencies understand very well.

Health care providers should also note that COVID-era flexibility did not create a permanent free pass. Emergency rules may have expanded access and sped reimbursement, but they did not erase medical necessity, documentation standards, anti-kickback rules, or truth-in-billing obligations. Once the emergency fog cleared, agencies had more time to ask the uncomfortable question: what exactly was billed here, and why?

3. Consumer fraud and deceptive COVID marketing

Not every COVID-19 fraud claim in 2024 involved government reimbursement. Consumer-protection agencies kept going after deceptive product claims too. That included false or misleading statements about whether masks met N95 standards, whether supplements could treat or prevent COVID-19, and whether sellers could deliver desperately needed PPE “next day” when they clearly could not.

This category matters because it shows pandemic fraud enforcement is not limited to classic grant and loan cases. Companies that used COVID fear as a marketing tool also remained at risk. In 2024, the FTC kept making it clear that pandemic-related deception can still lead to money judgments, bans, and refund programs long after the original ads have vanished from the internet. The internet forgets nothing, and neither do regulators.

4. Tax-credit scrutiny, especially ERC claims

Another major 2024 theme was cleanup around the Employee Retention Credit. The ERC was designed to help eligible employers during the pandemic, but it also became catnip for aggressive promoters promising easy money. By 2024, the IRS was openly urging businesses to review questionable ERC filings, withdraw improper claims, or use voluntary disclosure options. That was not subtle. It was a giant federal billboard saying, “Please fix this before we do.”

The ERC story fits the larger COVID-19 fraud picture perfectly. A crisis program launches quickly, legitimate relief meets opportunistic marketing, promoters oversimplify the rules, and later the government starts sorting honest mistakes from bad-faith claims. Businesses that touched ERC filings in 2024 had every reason to re-check eligibility standards, supporting records, and advisor assumptions.

Why the False Claims Act Remains the Star Player

The False Claims Act stayed central in 2024 because it is built for exactly this kind of cleanup. It allows the government to pursue entities that knowingly submitted false claims for payment or used false statements material to a payment decision. It also allows private whistleblowers, called relators, to file qui tam suits on the government’s behalf and share in recoveries if the case succeeds.

That whistleblower feature is a big deal. Pandemic-era misconduct often happened inside businesses, labs, nonprofits, staffing companies, lenders, and consulting chains. People saw what was submitted. People saw who said “close enough.” And people occasionally got tired of being asked to pretend that duplicate borrowers, strange payroll math, or medically unnecessary testing all looked normal. A hot whistleblower pipeline means COVID-19 fraud claims can keep surfacing even years after the original conduct.

The False Claims Act also helps explain why 2024 enforcement felt less like an ending and more like a second season. Civil cases move slower than breaking-news cycles. They require investigations, data review, negotiations, and sometimes sealed whistleblower complaints that stay hidden before they burst into public view. By the time many pandemic fraud matters become visible, they have already been developing for quite a while.

Specific 2024 Examples That Show the Trend

The strongest proof that enforcement continued in 2024 is not theory. It is the case docket. Federal authorities announced PPP-related False Claims Act settlements involving nonprofits, dental operations, and other businesses accused of obtaining or retaining funds they were not entitled to receive. Health care authorities continued announcing actions tied to COVID testing fraud, uninsured program billing, vaccine card schemes, and kickback-fueled laboratory conduct.

Consumer-protection enforcement also stayed active. The FTC pursued companies that allegedly misrepresented masks as N95-grade and targeted sellers that made false shipping promises for PPE during the height of demand. That tells businesses something useful: a COVID-related misrepresentation does not become harmless just because the market has moved on. The legal theory is still there, waiting patiently like leftovers in the back of the fridge, except a lot less pleasant.

And then there is oversight data. Pandemic watchdogs and inspectors general continued publishing findings, recommendations, and fraud estimates in 2024, giving investigators more leads and giving prosecutors more context. Oversight reports do not always grab headlines, but they are often where tomorrow’s enforcement theories quietly begin.

What Businesses and Providers Should Do Now

Audit old pandemic claims before someone else does

If your organization received PPP, EIDL, ERC, uninsured-program reimbursement, or COVID-related Medicare payment, do not assume time has made the issue disappear. Review what was submitted, who approved it, what support exists, and whether the records still match the certifications. A boring internal audit now is usually cheaper than a very exciting civil investigative demand later.

Document the “why,” not just the “what”

Many COVID-era disputes turn on whether a claim was merely imperfect or knowingly false. That is where contemporaneous records matter. If a business made a judgment call under emergency conditions, it should be able to show the reasoning, the information available at the time, and the steps taken to verify eligibility. Good records do not guarantee victory, but bad records practically send an engraved invitation to trouble.

Take whistleblower risk seriously

Internal complaints about billing, certifications, eligibility, or marketing should never be treated as office background noise. In the COVID-19 fraud context, today’s ignored employee email can become tomorrow’s qui tam complaint. When staff raise concerns, investigate them like adults, fix what needs fixing, and avoid the universal corporate mistake of assuming silence means agreement.

Consider voluntary correction where available

For some issues, especially tax-related ones such as improper ERC claims, government programs have offered ways to correct mistakes. Not every problem is fixable through a formal disclosure channel, and not every mistake will be viewed kindly, but organizations should at least evaluate the option. Self-correction may not feel glamorous, but neither does explaining preventable conduct to federal investigators.

The Big Picture for 2024 and Beyond

The deeper story in 2024 was not simply that agencies were still busy. It was that pandemic-fraud enforcement matured. Early pandemic oversight focused on warnings, emergency controls, and rapid response. By 2024, the government had more data, more referrals, more whistleblower suits, and more room to connect the dots. That is when enforcement gets sharper.

So yes, enforcing COVID-19 fraud claims continued in 2024, and for entirely logical reasons. The money was massive. The controls were uneven. The records are durable. The statutes remain useful. And the incentives for whistleblowers, inspectors general, and civil enforcers are still firmly in place. Businesses hoping the issue would simply age out learned a tough lesson: pandemic fraud may have started in a crisis, but its consequences are settling in for the long haul.

What the 2024 Experience Looked Like on the Ground

One of the most revealing parts of 2024 was how ordinary many of these cases looked at first. A borrower was not always a cartoon villain twirling a mustache over a fake PPP application. Sometimes it looked like a real business that convinced itself that rough estimates were “good enough,” that affiliate rules were “too technical,” or that a second application could be justified if no one looked too closely. In health care matters, the same pattern appeared in different clothes: bill first, explain later, and hope the volume of claims hides the weakness of the documentation. That mindset worked for a while in the middle of the emergency. It worked much less well once investigators had time.

Compliance officers and finance teams also had a rougher job than many people expected. By 2024, they were no longer just storing old pandemic files. They were reconstructing decisions made during chaos, trying to understand who approved what, why a certain certification was made, or why one payroll number showed up in three different places wearing three different hats. In many organizations, the real stress was not only legal exposure. It was operational memory loss. People had left. Advisers had changed. Email chains were incomplete. The pandemic may have felt recent in cultural terms, but in document-retrieval terms it was already ancient history.

Whistleblowers had their own 2024 experience, and it was not always dramatic at the beginning either. Many claims likely started with somebody inside an organization noticing that the explanation kept changing. A lab billed for tests patients never expected. A relief-loan applicant described one ownership structure to the bank and another to the government. A company told consumers a mask performed at one level even though the evidence did not support it. Employees and competitors often spot those inconsistencies long before a complaint is filed. By the time a case becomes public, the person who raised the issue may have spent months trying to get someone internally to take it seriously.

Government agencies, meanwhile, seemed to spend 2024 acting less like emergency responders and more like forensic accountants with better software. Oversight bodies used analytics, cross-program comparisons, fraud referrals, and claims reviews to identify patterns that would have been harder to catch in real time. That changed the emotional tone of enforcement. The early pandemic years were full of urgency and improvisation. The 2024 phase felt colder, slower, and more methodical. That is often worse for targets because methodical enforcement tends to arrive with spreadsheets, not just suspicion.

Perhaps the clearest real-world lesson from 2024 was this: the line between “we made a mistake during a crisis” and “we submitted a false claim” depends heavily on conduct after the fact. Organizations that reviewed records, corrected problems, preserved documentation, and responded carefully generally put themselves in a better position. Organizations that ignored warning signs, doubled down on weak explanations, or treated pandemic relief as free money tended to age very badly once oversight matured. The pandemic may have been exceptional, but the enforcement lesson was wonderfully old-fashioned: if you ask the government for money, you should be prepared to prove you deserved it.